Christian Howell Appointed as CEO of Cognito Therapeutics, Poised to Advance Alzheimer’s Therapy Development

Cambridge, MA, August 20, 2024 (Business Wire) -- Christian Howell has been named CEO of Cognito Therapeutics, succeeding Brent Vaughan. Prior to Cognito, which Howell joined in 2023 as the CEO, Howell was the SVP and GM of Aetion's Medical Device and Diagnostic group after an almost 15-year tenure at Medtronic.  Howell will focus on making its therapies available to patients suffering from Alzheimer's disease.

Read full article here.